雲天化(600096.SH):雲南省國資委批准煤化集團轉讓大為制氨93.89%股權
格隆匯7月23日丨雲天化(600096.SH)公佈,公司擬收購煤化集團持有的大為制氨93.89%股權。
近日,公司收到煤化集團通知,已取得《雲南省國資委關於雲南煤化工集團有限公司非公開協議轉讓雲南大為制氨有限公司股權的批覆》。雲南省國資委同意煤化集團將其所持大為制氨93.89%股權以非公開協議方式轉讓給公司。轉讓價格以經國資委備案的資產評估結果為基礎確定。並要求煤化集團會同相關企業依法合規開展股權轉讓工作,及時辦理產權變動和工商變更等手續。本次交易股權評估價值尚須經雲南省國資委備案,相關事項尚須提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.